Metropolitan Life Insurance CO Gt Biopharma, Inc. Transaction History

Metropolitan Life Insurance CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.68 - $15.26 $58,663 - $134,013	-8,782 Closed	0 $0
Q2 2021 Jun 21, 2023	BUY	$7.19 - $18.96 $63,142 - $166,506	8,782 New	8,782 $136,000
Q2 2021 Mar 30, 2023	BUY	$7.19 - $18.96 $63,142 - $166,506	8,782 New	8,782 $136,000
Q2 2021 Aug 16, 2021	BUY	$7.19 - $18.96 $63,142 - $166,506	8,782 New	8,782 $136,000

564

Ticker GTBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,557,700
Market Cap $81.7M
Description
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.